$MED
MEDIFAST INC

2016 Q2 Form 10-Q Financial Statement

#000114420416117690 Filed on August 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q4 2015 Q2
Revenue $71.14M $61.30M $72.16M
YoY Change -1.41% -1.61% -3.44%
Cost Of Revenue $17.90M $16.10M $18.99M
YoY Change -5.76% -6.94% -0.86%
Gross Profit $53.20M $45.20M $53.17M
YoY Change 0.06% 0.44% -4.33%
Gross Profit Margin 74.78% 73.74% 73.68%
Selling, General & Admin $48.20M $39.70M $44.50M
YoY Change 8.3% -2.7% -2.64%
% of Gross Profit 90.6% 87.83% 83.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.700M $1.800M
YoY Change -22.22% -19.05% -29.19%
% of Gross Profit 2.63% 3.76% 3.39%
Operating Expenses $48.20M $39.70M $44.50M
YoY Change 8.3% -2.7% -2.64%
Operating Profit $5.000M $5.500M $8.663M
YoY Change -42.28% 30.95% -12.15%
Interest Expense $100.0K $200.0K $164.0K
YoY Change -39.02% -33.33% -3.53%
% of Operating Profit 2.0% 3.64% 1.89%
Other Income/Expense, Net $68.00K $200.0K $165.0K
YoY Change -58.79% -166.67% -29.18%
Pretax Income $5.100M $5.900M $8.828M
YoY Change -42.23% 40.48% 1.65%
Income Tax $1.700M $2.000M $2.981M
% Of Pretax Income 33.33% 33.9% 33.77%
Net Earnings $3.400M $3.900M $6.248M
YoY Change -45.58% -214.71% 9.23%
Net Earnings / Revenue 4.78% 6.36% 8.66%
Basic Earnings Per Share $0.29 $0.51
Diluted Earnings Per Share $0.29 $327.7K $0.51
COMMON SHARES
Basic Shares Outstanding 11.81M shares 11.76M shares 12.07M shares
Diluted Shares Outstanding 11.88M shares 12.16M shares

Balance Sheet

Concept 2016 Q2 2015 Q4 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.60M $109.1M $102.2M
YoY Change -22.1% 41.56% 1.58%
Cash & Equivalents $58.60M $42.04M $37.15M
Short-Term Investments $79.59M $67.11M $65.04M
Other Short-Term Assets $5.200M $3.300M $5.700M
YoY Change -8.77% -51.47% 26.67%
Inventory $11.40M $13.34M $12.40M
Prepaid Expenses
Receivables $1.627M $1.633M $1.991M
Other Receivables $0.00 $1.600M $1.000M
Total Short-Term Assets $97.80M $88.07M $86.10M
YoY Change 13.59% 7.52% -6.67%
LONG-TERM ASSETS
Property, Plant & Equipment $20.10M $29.03M $31.10M
YoY Change -35.37% -13.29% -16.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $165.0K $205.0K $200.0K
YoY Change -17.5% -58.75% -50.0%
Total Long-Term Assets $20.30M $29.25M $31.30M
YoY Change -35.14% -13.95% -16.49%
TOTAL ASSETS
Total Short-Term Assets $97.80M $88.07M $86.10M
Total Long-Term Assets $20.30M $29.25M $31.30M
Total Assets $118.1M $117.3M $117.4M
YoY Change 0.6% 1.22% -9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.40M $22.50M $21.30M
YoY Change 5.16% 84.43% -15.48%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $200.0K $200.0K
YoY Change -50.0% 0.0% 0.0%
Total Short-Term Liabilities $24.30M $23.56M $22.81M
YoY Change 6.52% -12.54% -12.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% -75.0%
Other Long-Term Liabilities $0.00 $300.0K $1.000M
YoY Change -100.0% -89.29%
Total Long-Term Liabilities $0.00 $300.0K $1.100M
YoY Change -100.0% -90.0% 175.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.30M $23.56M $22.81M
Total Long-Term Liabilities $0.00 $300.0K $1.100M
Total Liabilities $26.80M $28.74M $29.19M
YoY Change -8.17% -18.89% -9.44%
SHAREHOLDERS EQUITY
Retained Earnings $90.22M $88.63M $89.59M
YoY Change 0.7% 12.34% -18.1%
Common Stock $12.00K $12.00K $12.00K
YoY Change 0.0% -98.95% -7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.321M
YoY Change -76.66%
Treasury Stock Shares 103.1K shares
Shareholders Equity $91.27M $88.58M $88.20M
YoY Change
Total Liabilities & Shareholders Equity $118.1M $117.3M $117.4M
YoY Change 0.59% 1.22% -9.52%

Cashflow Statement

Concept 2016 Q2 2015 Q4 2015 Q2
OPERATING ACTIVITIES
Net Income $3.400M $3.900M $6.248M
YoY Change -45.58% -214.71% 9.23%
Depreciation, Depletion And Amortization $1.400M $1.700M $1.800M
YoY Change -22.22% -19.05% -29.19%
Cash From Operating Activities $11.00M $2.100M $7.700M
YoY Change 42.86% 133.33% 35.09%
INVESTING ACTIVITIES
Capital Expenditures -$700.0K -$1.200M -$500.0K
YoY Change 40.0% -58.62% -70.59%
Acquisitions
YoY Change
Other Investing Activities $3.700M $2.500M -$200.0K
YoY Change -1950.0% -933.33% -120.0%
Cash From Investing Activities $3.000M $1.300M -$700.0K
YoY Change -528.57% -140.63% -12.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.800M -400.0K -3.400M
YoY Change -17.65% -55.56% -76.22%
NET CHANGE
Cash From Operating Activities 11.00M 2.100M 7.700M
Cash From Investing Activities 3.000M 1.300M -700.0K
Cash From Financing Activities -2.800M -400.0K -3.400M
Net Change In Cash 11.20M 3.000M 3.600M
YoY Change 211.11% -193.75% -138.3%
FREE CASH FLOW
Cash From Operating Activities $11.00M $2.100M $7.700M
Capital Expenditures -$700.0K -$1.200M -$500.0K
Free Cash Flow $11.70M $3.300M $8.200M
YoY Change 42.68% -13.16% 10.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42037000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
13335000 USD
CY2016Q2 us-gaap Short Term Investments
ShortTermInvestments
20975000 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
25072000 USD
CY2016Q2 us-gaap Prepaid Taxes
PrepaidTaxes
0 USD
CY2015Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1549000 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3473000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2886000 USD
CY2016Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1703000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1208000 USD
CY2016Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2015Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
353000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
165000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
205000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
19000 USD
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
19000 USD
CY2016Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
111000 USD
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
219000 USD
CY2016Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
482000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
841000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2475000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4890000 USD
CY2016Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
22000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
288000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
124000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
90219000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
88634000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
91265000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
88584000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118072000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117326000 USD
us-gaap Revenues
Revenues
143489000 USD
us-gaap Revenues
Revenues
145525000 USD
us-gaap Cost Of Revenue
CostOfRevenue
37070000 USD
us-gaap Cost Of Revenue
CostOfRevenue
38588000 USD
us-gaap Gross Profit
GrossProfit
106419000 USD
us-gaap Gross Profit
GrossProfit
106937000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
95127000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91762000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
11292000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
15175000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
180000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
296000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
149000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11451000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3794000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5357000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
7657000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
10263000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
429000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11817000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11891000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12176000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.65
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.85
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.64
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.84
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.04
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2015Q2 us-gaap Revenues
Revenues
72161000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
18994000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8663000 USD
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
164000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8828000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2981000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5847000 USD
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
401000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
6248000 USD
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11811000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12069000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11884000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12159000 shares
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.29
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.48
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.29
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.48
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-56000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
92000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-176000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-176000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1192000 USD
med Adjustments To Additional Paid In Capital Net Shares Repurchased For Employee Taxes
AdjustmentsToAdditionalPaidInCapitalNetSharesRepurchasedForEmployeeTaxes
743000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3491000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6072000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
299000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-272000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-596000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2905000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4069000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1095000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
18996000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
20961000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4211000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1095000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
108000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
115000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
45000 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
743000 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
875000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
105000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6015000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
429000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1192000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1105000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-77000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
134000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
341000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1971000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3311000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
587000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
257000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-40000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-335000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-229000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3123000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18724000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17838000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
26741000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4450000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
22432000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4172000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
655000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
753000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1373000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4211000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
299000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
105000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
165000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6376000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-4057000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6376000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4057000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
14000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16573000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12686000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24459000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37145000 USD
us-gaap Interest Paid
InterestPaid
5000 USD
us-gaap Interest Paid
InterestPaid
14000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
3661000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
305000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
5929000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
us-gaap Dividends Cash
DividendsCash
3100000 USD
us-gaap Dividends Cash
DividendsCash
0 USD
CY2016Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
3370000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3666000 USD
CY2016Q2 us-gaap Retail Related Inventory
RetailRelatedInventory
836000 USD
CY2015Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
788000 USD
CY2016Q2 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
561000 USD
CY2015Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
635000 USD
CY2016Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7003000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8545000 USD
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
406000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
299000 USD
CY2016Q2 med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
-73000 shares
CY2015Q2 med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
-90000 shares
med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
-74000 shares
med Effect Of Dilutive Common Stock Equivalent
EffectOfDilutiveCommonStockEquivalent
-91000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
98000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
54375 shares
CY2015Q2 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
16000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0111 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4222 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0356 pure
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
26.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
26.43
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
26.95
us-gaap Sales Revenue Net
SalesRevenueNet
143489000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
145525000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
71144000 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
72161000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
694000 USD
us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
0 USD
us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
-265000 USD
CY2016Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 USD
CY2015Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
649000 USD
CY2016Q2 us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
0 USD
CY2015Q2 us-gaap Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
-248000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Other Assets
DisposalGroupIncludingDiscontinuedOperationOtherAssets
19000 USD
CY2016Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
19000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
482000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
22000 USD
CY2016Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
504000 USD
med Adjustments Recorded During Period
AdjustmentsRecordedDuringPeriod
213000 USD
med Payments For Expenses Incurred
PaymentsForExpensesIncurred
838000 USD
CY2016Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
504000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
504000 USD
us-gaap Restructuring Charges
RestructuringCharges
1343000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
356000 USD
CY2016Q2 us-gaap Restructuring Reserve
RestructuringReserve
987000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
MEDIFAST INC
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
MED
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11848360 shares
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1356000 USD
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
910000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2016Q2 med Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
514000 USD
CY2015Q4 med Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
417000 USD
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12024000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12014000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11848000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11797000 shares
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
165000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
445000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
88000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-26000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3321000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
6083000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="WIDTH: 13.5pt"> <div>1.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Basis of Presentation</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 13.5pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The condensed unaudited interim consolidated financial statements included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;), for interim information and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for reporting on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by GAAP for annual fiscal reporting periods. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 13.5pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 13.5pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The results of operations for the three and six months ended June 30, 2016 are not necessarily indicative of results that may be expected for the year ending December 31, 2016. The accompanying condensed unaudited interim consolidated financial statements should be read in conjunction with the 2015 audited financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K filed for the year ended December 31, 2015 (&#8220;2015 Form 10-K&#8221;).</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
78000 USD
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2016Q2 us-gaap Interest Receivable
InterestReceivable
177000 USD
CY2016Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
79585000 USD
CY2016Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
20975000 USD
us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
134000 USD
CY2015Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1129000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities Current
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
482000 USD
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
67237000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
372000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
583000 USD
CY2015Q4 us-gaap Interest Receivable
InterestReceivable
83000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
67109000 USD
CY2015Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
25072000 USD
CY2014 med Corporate Centers Sold During Period
CorporateCentersSoldDuringPeriod
41 pure
med Corporate Centers Sold During Period
CorporateCentersSoldDuringPeriod
24 pure
med Corporate Centers Sold During Period
CorporateCentersSoldDuringPeriod
17 pure
med Corporate Centers Closed During Period
CorporateCentersClosedDuringPeriod
34 pure
CY2016Q2 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-33000 USD
us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-77000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1627000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1633000 USD
CY2016Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
6100000 USD

Files In Submission

Name View Source Status
0001144204-16-117690-index-headers.html Edgar Link pending
0001144204-16-117690-index.html Edgar Link pending
0001144204-16-117690.txt Edgar Link pending
0001144204-16-117690-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20160630.xml Edgar Link completed
med-20160630.xsd Edgar Link pending
med-20160630_cal.xml Edgar Link unprocessable
med-20160630_def.xml Edgar Link unprocessable
med-20160630_lab.xml Edgar Link unprocessable
med-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v445099_10q.htm Edgar Link pending
v445099_ex31-1.htm Edgar Link pending
v445099_ex31-2.htm Edgar Link pending
v445099_ex32-1.htm Edgar Link pending